Loading
Loading
Research Overview
Multi-peptide blend combining GHK-Cu and cosmetic peptides targeting skin collagen synthesis, pigmentation regulation via MC1R, and antioxidant pathways to support skin elasticity, hydration, and evenness in research models.
Cosmetic peptide research encompasses a broad class of short synthetic peptides studied in cell culture and ex vivo skin tissue models for their effects on dermal fibroblast biology, collagen and elastin synthesis, melanocyte activity, and epidermal cell turnover. The preclinical research basis for cosmetic peptide blends draws on studies of individual component peptides in relevant biological model systems, including primary fibroblast cultures, reconstructed skin models, and ex vivo skin explant assays.
Key research themes relevant to cosmetic peptide blend biology include the regulation of type I and type III collagen gene expression and secretion by fibroblasts, the modulation of matrix metalloproteinase (MMP) activity affecting extracellular matrix degradation, melanogenesis regulation through tyrosinase and melanocyte receptor biology, and epidermal growth factor receptor pathway activation influencing keratinocyte biology.
Preclinical cell-based research has examined individual bioactive peptides including GHK-Cu (copper tripeptide), acetyl hexapeptide-3 (argireline), palmitoyl pentapeptide-4 (matrixyl), and other signalling peptides for their effects on fibroblast collagen synthesis, wrinkle biology, and skin regeneration parameters in laboratory model systems. Multi-peptide formulations in research settings are examined for potential complementary or synergistic effects on these biological endpoints.
Sold strictly as a research chemical for non-human, in-vitro, and laboratory use
FDA approved compound
Prescription availability in Australia and internationally
In Australia, glow blend — cosmetic peptide has no TGA approval for therapeutic use. It is sold by Capital Peptides strictly as a research chemical for non-human, in-vitro, and laboratory research use only.
Glow Blend — Cosmetic Peptide research is most relevant to protocols examining:
Comprehensive skin health and anti-ageing research
Multi-target cosmetic peptide mechanism studies
Collagen synthesis, pigmentation, and antioxidant pathway research
Researchers seeking a combined cosmetic peptide protocol
Initial phase
Compound begins accumulating in target tissue. Most researchers note subtle changes by end of week one. Baseline measurements recommended.
Early response
Measurable effects begin to establish. Mid-cycle assessment is appropriate at this point in well-designed protocols.
Peak activity window
Effects compound in this window. Given limited human data, careful documentation is important.
Washout & review
Allow full washout (~5× half-life: Variable (component-dependent)). Review data, confirm baseline recovery before any repeat protocol.
Multi-peptide blend combining GHK-Cu and cosmetic peptides targeting skin collagen synthesis, pigmentation regulation via MC1R, and antioxidant pathways to support skin elasticity, hydration, and evenness in research models.
| Parameter | Value |
|---|---|
| Dose range | Per blend formulation |
| Schedule | Daily |
| Route | Subcutaneous |
| Half-life | Variable (component-dependent) |
Available from Capital Peptides
For research use only. Capital Peptides products are not approved by the TGA for therapeutic use. By purchasing you confirm you are a licensed research entity or qualified professional.
